Personal Products

According to Piper Jaffray, Physicians Formula (NASDAQ: FACE) gross revenue increased in the high-single-digits during FQ2. Piper Jaffray said that this was offset by $2.7 million in incremental consumer and trade promotion spending (a contra-revenue item), thus net sales were up 0.6% y/y in FQ2...

Piper Jaffray has lowered the price target on Physicians Formula (NASDAQ: FACE) from $5 to $4 and maintains its Neutral rating.

Jefferies made a number of rating and price target changes in a research report published today. AstraZeneca PLC (NYSE: AZN) had its rating upgraded from Underperform to Hold. On Wednesday, AZN lost 0.34% of its value to finish the day at $47. Its shares continued to slide in today's pre-market...

Alpha Natural Resources Inc (NYSE: ANR) is expected to report its Q2 EPS at $1.12 on revenue of $1.47 billion. Kraft Foods Inc (NYSE: KFT) is projected to report its Q2 EPS at $0.58 on revenue of $13.15 billion. CIGNA Corporation (NYSE: CI) is estimated to report its Q2 EPS at $1.29 on revenue of...

Stifel Nicolaus is out with its report today on Nu Skin Enterprises (NYSE: NUS), raising its PT from $43 to $44. In its report, Stifel Nicolaus writes, "We lift our 2011 and 2012 EPS estimates to $2.47 (was $2.40) and $2.86 (was $2.79), respectively. We also increase our 12-month price target to $...

J.P. Morgan is out with its report today on Nu Skin Enterprises (NYSE: NUS), raising its PT from $37 to $48. In its report, J.P. Morgan writes, "We rate NUS Overweight. We think valuation is compelling with NUS currently trading at about 14.4x our revised FY12 estimate, which is below their five-...

Deutsche Bank has raised its price target from $43 to $45 on Nu Skin Enterprises (NYSE: NUS), citing the company's growth as the reason. In the report, Deutsche Bank writes, “Company is successfully lapping ageLOC launch in most regions, showing solid growth on growth ahead of Galvanic Spa Body...

JP Morgan has raised the price target on Nu Skin Enterprises (NYSE: NUS) from $37 to $48 and maintains its Overweight rating.

Deutsche Bank has raised the price target on Nu Skin Enterprises (NYSE: NUS) from $43 to $45 and maintains its Buy rating.

Stocks trading at or near 52-week highs and lows provide excellent trading opportunities, as volatility tends to increase at such levels and exit/entry points become more clearly defined. The following stocks hit new 52-week highs in Monday's trading session (listed from highest total volume to...

There have been a handful of companies that I have missed, or chosen to stay out of, the past few years - and Herbalife (HLF) is one of them.  Nutrion/weight loss companies have a history of big runs (Nutrisystem was the last darling of this sector) and then blow ups but Herbalife has prevailed for...

According to Jefferies, Avon Products (NYSE: AVP) looks for acceleration in the 2H. Jefferies said that it is leaving its EPS estimates unchanged, as Avon reported what was largely an in-line Q2. “While management generally delivered on its stated 1H plans of +LSD local currency sales growth and...

Jefferies & Company has lowered the price target on Avon Products (NYSE: AVP) from $35 to $33 and maintains its Buy rating.

Stocks trading at or near 52-week highs and lows provide excellent trading opportunities, as volatility tends to increase at such levels and exit/entry points become more clearly defined. The following stocks hit new 52-week highs in Monday's trading session (listed from highest total volume to...

Herbalife (NYSE: HLF) reported another blowout quarter on Monday after the closing bell. The company reported EPS of $0.88, which beat analysts' consensus EPS estimates of $0.75 by a wide margin. Revenues came in at $879.7 million, versus Street consensus of $829 million. Herbalife (HLF) also...